A pilot study of anti-nephrin antibodies in podocytopaties among adults.

Natalia V ChebotarevaAnatoliy VinogradovYevgeniya BirukovaIgor AlentovNatalia SergeevaDaria ChemodanovaAlexey S KononikhinSergey V Moiseev

Published in: Nephrology (Carlton, Vic.) (2023)

The level of anti-nephrin antibodies was found to be significantly higher in patients with MCD and pFSGS compared to those with sFSGS, MN, and healthy subjects. Anti-nephrin antibodies in MCD and primary FSGS may be associated with the severity of podocytopathies, however they did not have an impact on the response to therapy.

Keyphrases

stem cells
cell therapy
smoking cessation
ionic liquid